Elevating Liver Disease Globally: How Do We Get There? | AASLD

Elevating Liver Disease Globally: How Do We Get There?

Nov 09 2025
Convention Center: Salon GH, Level 1
3:45 PM - 4:45 PM

World Class Speakers

Grace Su, MD, FAASLD
Presenter

Grace Su, MD, FAASLD

University of Michigan Medical Center
Oren K Fix, MD, MSc, FAASLD
Presenter

Oren K Fix, MD, MSc, FAASLD

University of North Carolina at Chapel Hill
Melina I Manolas, MD, MPH
Presenter

Melina I Manolas, MD, MPH

Weill Cornell Medicine
Nelia Hernandez, MD
Panelist

Nelia Hernandez, MD

Hospital de Clinicas, Universidad de la Republica
Necati Ormeci, Prof
Panelist

Necati Ormeci, Prof

İstanbul Health and Technology University
Debbie L Shawcross, BSc, MBBS, PhD, FRCP
Panelist

Debbie L Shawcross, BSc, MBBS, PhD, FRCP

Roger Williams Institute of Liver Studies
Jeffrey V. Lazarus, PhD
Panelist

Jeffrey V. Lazarus, PhD

Barcelona Institute for Global Health
Catherine W Spearman, PhD
Panelist

Catherine W Spearman, PhD

University of Cape Town
Tamar H Taddei, MD, MD, FAASLD
Moderator

Tamar H Taddei, MD, MD, FAASLD

Yale University
Mazen Noureddin
Moderator

Mazen Noureddin

Houston Research Institute and Houston Methodist Hospital

Description

This is a Healthy Liver, Healthy Lives (HLHL) symposium bringing the global community together to elevate liver disease as a global health priority.

Journey Maps

Presentations

3:45 PM - 3:47 PM
Oct 09 2026
Convention Center - Salon GH, Level 1

Welcome

Grace Su, MD, FAASLD , Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
Cirrhosis and Portal Hypertension
Drug-Induced Liver Injury
Global
Hepatitis
Liver Cancer
MASLD
Public Health
3:47 PM - 3:57 PM
Oct 09 2026
Convention Center - Salon GH, Level 1

Global Liver Disease - Tip of the Iceberg

Oren K Fix, MD, MSc, FAASLD , Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
Cirrhosis and Portal Hypertension
Drug-Induced Liver Injury
Global
Hepatitis
Liver Cancer
MASLD
Public Health
3:57 PM - 4:07 PM
Oct 09 2026
Convention Center - Salon GH, Level 1

Making Liver Disease Relevant to a Global Audience/Non-hepatologist Audience

Melina I Manolas, MD, MPH , Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
Cirrhosis and Portal Hypertension
Drug-Induced Liver Injury
Global
Hepatitis
Liver Cancer
MASLD
Public Health
4:07 PM - 4:42 PM
Oct 09 2026
Convention Center - Salon GH, Level 1

Panel Discussion

Tamar H Taddei, MD, MD, FAASLD , Moderator
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
Cirrhosis and Portal Hypertension
Drug-Induced Liver Injury
Global
Hepatitis
Liver Cancer
MASLD
Public Health
4:42 PM - 4:45 PM
Oct 09 2026
Convention Center - Salon GH, Level 1

Closing

Mazen Noureddin , Moderator
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
Cirrhosis and Portal Hypertension
Drug-Induced Liver Injury
Global
Hepatitis
Liver Cancer
MASLD
Public Health

Objectives

  • Describe the global burden of liver disease and explain why it is underdiagnosed.
  • Describe ways that liver disease could be elevated as a priority with a non-hepatologist audience, including primary care providers.
  • Discuss ways hepatology providers can facilitate the early recognition of liver disease in the community.